ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Key Highlights
- ➤ORIC management to participate in three November healthcare investor conferences
- ➤Fireside chats scheduled November 10, 11, and 18, 2026
- ➤ORIC plans one-on-one investor meetings at all three conferences
- ➤Clinical-stage candidates include rinzimetostat and enozertinib
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in the following investor conferences in November: * Guggenheim’s 3rd Annual Healthcare Innovation Conference – Participating in a fireside chat on Tuesday, November 10, 2026, at 10:30 a.m. ET. Management will also be participating in one-on-one meetings.
* Stifel 2026 Healthcare Conference – Participating in a fireside chat on Wednesday, November 11, 2026, at 2:00 p.m. ET. Management will also be participating in one-on-one meetings.
Get started
Create a free account to read the full story.